S. J. Robert, J. L. Zugaza, R. Fischmeister, A. M. Gardier, and F. Lezoualc'h, J. Biol. Chem, vol.276, pp.44881-44888, 2001.

S. Cho and Y. Hu, Exp. Neurol, vol.203, pp.274-278, 2007.

F. Lezoualc'h, Exp. Neurol, vol.205, pp.325-329, 2007.

R. Bureau, M. Boulouard, F. Dauphin, F. Lezoualc'h, and S. Rault, Curr. Top. Med. Chem, vol.10, pp.527-553, 2010.

L. M. Gaster and F. D. King, Med. Res. Rev, vol.17, pp.163-214, 1997.

M. L. López-rodríguez, M. J. Morcillo, B. Benhamú, and M. L. Rosado, J. Comput. Aided. Mol. Des, vol.11, pp.589-599, 1997.

R. Bureau, C. Daveu, S. Lemaître, F. Dauphin, H. Landelle et al., investigué mais les résultats ont indiqué que ce radioligand pouvait potentiellement interagir avec la glycoprotéine P (P-GP) rendant son utilisation inappropriée, J. Chem. Inf. Comput. Sci, vol.42, p.37, 2002.

B. R. Kornum, N. M. Lind, N. Gillings, L. Marner, F. Andersen et al., Blood Flow Metab, vol.29, pp.186-196, 2009.

A. Gee, L. Martarello, J. Passchier, M. Wishart, C. Parker et al., Curr. Radiopharm, vol.1, pp.110-114, 2008.

L. Marner, N. Gillings, R. A. Comley, W. F. Baaré, E. A. Rabiner et al., J. Nucl. Med, vol.50, pp.900-908, 2009.

R. Xu, J. Hong, C. L. Morse, and V. W. Pike, J. Med. Chem, vol.53, pp.7035-7047, 2010.

T. G. Lohith, R. Xu, T. Tsujikawa, C. L. Morse, K. B. Anderson et al., , vol.68, pp.613-623, 2014.

F. Caillé, T. J. Morley, A. A. Tavares, C. Papin, N. M. Twardy et al., Bioorganic Med. Chem. Lett, vol.23, pp.6243-6247, 2013.

H. J. Buiter, A. D. Windhorst, M. C. Huisman, J. H. De-maeyer, J. A. Schuurkes et al., , p.24, 2013.

, 3-c]quinolin-5-yl)oxy)methyl)piperidin-1-yl)ethyl)-2,3-dihydro1H-isoindole-1,3-dione 13a, vol.2, pp.3-4

, 3-c]quinolin-5-yl)oxy)methyl]piperidine-1-carboxylate 10 (900 mg, 1.73 mmol) and following the general procedure A. The crude product was dissolved in acetonitrile (50 mL) and N-(2-bromoethyl)phthalimide (526 mg, 2.08 mmol) and triethylamine (0.45 mL, 3.50 mmol) were added. The solution was stirred at 80°C for 24 hours and the white precipitate formed was filtered, vol.2

, 3-c]quinolin-5-yl)oxy)methyl)piperidin-1-yl)propyl)-2,3-dihydro1H-isoindole-1, vol.2, pp.3-13

, mmol) and following the general procedure A. The crude product was dissolved in acetonitrile (20 mL) and N-(3-bromopropyl)phthalimide (185 mg, 0.70 mmol) and triethylamine (0.19 mL, 1.4 mmol) were added. The solution was stirred at 80°C for 12 hours and the white precipitate formed was filtered, vol.2

, 3-c]quinolin-5-yl)oxy)methyl)piperidin-1-yl)butyl)-2,3-dihydro1H-isoindole-1, vol.2, pp.3-13

, mmol) and following the general procedure A. The crude product was dissolved in acetonitrile (20 mL) and N-(4-bromopbutyl)phthalimide (240 mg, 0.85 mmol) and triethylamine (0.19 mL, 1.4 mmol) were added. The solution was stirred at 80°C for 24 hours and the white precipitate formed was filtered, vol.2

, quinolin-5-yl)oxy)methyl)piperidine-1-yl)butyl)-2,3dihydro-1H-isoindole-1,3-dione (225 mg, 0.44 mmol) 31b and following the general procedure B. The crude product was dissolved in dichloromethane (10 mL) and dansyl chloride (113 mg, 0.42 mmol) and triethylamine (0.12 mL, 0.90 mmol) were added. The solution was stirred at room temperature for 15 minutes. The organic layer was washed with water (15 mL), extracted with dichloromethane (2 x 15 mL), dried over MgSO 4 , filtrated and evaporated. The residue was purified by silica gel chromatography using dichloromethane/methanol, pp.2-3

H. Nmr, 01 (d, 3 J = 2.0 Hz, 1H), 400 MHz, CDCl 3 ): ? = 9.08 (d, 3 J = 2.0 Hz, 1H), vol.9

. Hz, Hz, 1H), 7.53-7.47 (m, 3H), 7.16 (dd, 3 J = 7.6 Hz, 4 J = 0.8 Hz, 1H), vol.4, p.67

C. Nmr, 100 MHz, CDCl 3 ): ? = 158.4, 157.1 (d, J = 253 Hz), 151.9, 147.9, 145.7 (d, J = 4 Hz), 145.4, 135.9, vol.133

, quinolin-5-yl)oxy)methyl)piperidine-1-yl)hexyl)-2,3dihydro-1H-isoindole-1,3-dione (145 mg, 0.27 mmol) 31c and following the general procedure B. The crude product was dissolved in dichloromethane (7 mL) and dansyl chloride (62 mg, 0.23 mmol) and triethylamine (0.07 mL, 0.54 mmol) were added. The solution was stirred at room temperature for 15 minutes. The organic layer was washed with water (10 mL), extracted with dichloromethane (2 x 10 mL), dried over MgSO 4 , filtrated and evaporated. The residue was purified by silica gel chromatography using dichloromethane/methanol, pp.2-3

H. Nmr, 02 (d, 3 J = 2.0 Hz, 1H), 8.70-8.65 (m, 1H), 8.56-8.51 (m, 1H), 8.30-8.36 (m, 1H), 8.24 (dd, 3 J = 7.3 Hz, 4 J = 1.3 Hz, 1H), 400 MHz, CDCl 3 ): ? = 9.08 (d, 3 J = 2.0 Hz, 1H), vol.9

C. Nmr, 100 MHz, CDCl 3 ): ? = 158.4, 157.0 (d, J = 254 Hz), 152.2, 147.9, 145.7 (d, J = 4 Hz), vol.133

, CDCl 3 ): ? =-126.0 (t

, Tert-butyl N-(2-iodophenyl)carbamate 39b

, mmol), and following the general procedure G. The residue was purified by silica gel chromatography using petroleum ether/diethylether (90/10) as eluent affording the expected product as a white solid (180 mg

H. Nmr, CDCl 3 ): ? = 8.05 (dd, J = 8.3 Hz, J = 1.6 Hz, 1H), 7.40 (dd, J = 8.0 Hz, MHz, vol.1, issue.400

, Hz, 1H), 7.31 (td, J = 7.8 Hz, J = 1.6 Hz, 1H), 6.82 (bs, 1H)

C. Nmr, MHz, issue.100

H. Song, Y. Liu, Y. Liu, and Q. Wang, Org. Lett, vol.16, pp.3240-3243, 2014.

, mg, 1.34 mmol), and following the general procedure G. The residue was purified by silica gel chromatography using petroleum ether/diethylether (90/10) as eluent affording the expected product as a white solid (336 mg, vol.1, p.22

, Iodophenyl)benzamide 39f

, Starting from N-phenylbenzamide (200 mg, 1.01 mmol), and following the general procedure G. The residue was purified by silica gel chromatography using petroleum ether/diethylether (80/20) as eluent affording the expected product as a white solid (210 mg

, CDCl 3 ): ? = = 8.46 (dd, J = 8.3 Hz, J = 1.6 Hz 1H), 8.30 (bs, 1H), m, 2H), 7.82 (dd, J = 7.9 Hz, J = 1.5 Hz, 1H

J. Hz, Hz, J = 1.6 Hz, 1H)

C. Nmr, CDCl 3 ): ? = 165, MHz, vol.4, issue.100

A. Ahmed, R. Singha, and J. K. Ray, Tetrahedron Lett, vol.56, pp.2167-2171, 2015.

, fluorophenyl)pyrazine 46 (2.40 g, 9.71 mmol), Pyrazino[2,3-c]quinolin5(6H)-one was prepared according to the literature procedure and was obtained as a white solid, vol.2, p.75

H. Nmr, 400 MHz, DMSO-d 6 ): ? = 12.10 (br s, 1H), vol.9

C. Nmr, , p.51

, quinolin-5-yl)oxy)methyl)piperidine-1-carboxylate (50 mg, 0.13 mmol) and palladium acetate (29 mg, 0.13 mmol) was dissolved in acetonitrile (1 mL). The mixture was stirred a room temperature for 4 hours and filtrated. The precipitate was washed with acetonitrile

H. Nmr, CDCl 3 ): ? = 8.57 (d, 3 J = 2.6 Hz, 1H), MHz, vol.8, issue.400

. Hz,

F. Nmr, MHz, CDCl, vol.376, issue.5

, Hydrazine monohydrate (0.73 mL, 15 mmol) was added and the solution was stirred under reflux until the solubilisation of the mixture. Ethanol was evaporated and the residue was dissolved in dichloromethane (20 mL) at 0°C, filtered and concentrated under reduced pressure. The primary amine was dissolved in dichloromethane (20 mL) and the solution was cooled down to 0°C. Triethylamine (0.1 mL, 1.2 mmol) and methanesulfonyl chloride (0.05 mL, 0.7 mmol) were added to the solution and the mixture was stirred 5 min at 0°C and 5 min at room temperature, A round bottom flask was filled with 51 (520 mg, 0.45 mmol) and NIS (221 mg, 0.98 mmol) in dichloromethane (25 mL)

H. Nmr, CDCl 3 ): ? = 9, MHz, vol.8, issue.400

J. Hz, Hz, 1H), 7.19 (t, J = 8.9 Hz, 1H)

C. Nmr, 100 MHz, CDCl 3 ): ? = 157.7, 157.7 (d, J = 254 Hz), vol.140

, CDCl 3 ): ? =-124.0 (dd, J = 9.6 Hz, J =, vol.5

, mmol) and following the general procedure A. The crude product was then dissolved in acetonitrile (10 mL) and N-(2-bromoethyl)phthalimide (110 mg, 0.44 mmol) and triethylamine (0.10 mL, 0.72 mmol) were added. The solution was stirred at 80°C for 24 hours and the white precipitate formed was filtered, washed with acetonitrile (2 x 10 mL). The precipitate was dissolved in ethanol (15 mL) and following the general procedure B. The primary amine was dissolved in dichloromethane (10 mL) and the solution was cooled down to 0°C. Triethylamine (0.10 mL, 0.72 mmol) and methanesulfonyl chloride (0.02 mL, 0.30 mmol) were added to the solution and the mixture was stirred 5 min at 0°C and 5 min at room temperature. The organic layer was washed with water (15 mL), dried over MgSO 4 , filtrated and evaporated. The residue was purified by silica gel chromatography using dichloromethane/methanol, vol.2

H. Nmr, 02 (d, 3 J = 2.0 Hz, 1H), 8.71-8.64 (m, 1H, 400 MHz, CDCl 3 ): ? = 9.09 (d, 3 J = 2.0 Hz, 1H), vol.9

F. Nmr, CDCl 3 ): ? =-126

, 48 mmol) and following the general procedure A. The crude product was then dissolved in acetonitrile (15 mL) and N-(2-bromoethyl)phthalimide (144 mg, 0.58 mmol) and triethylamine (0.13 mL, 0.96 mmol) were added. The solution was stirred at 80°C for 24 hours and the white precipitate formed was filtered, washed with acetonitrile (2 x 10 mL). The precipitate was dissolved in ethanol (20 mL) and following the general procedure B. The primary amine was dissolved in dichloromethane (15 mL) and the solution was cooled down to 0°C. Triethylamine (0.13 mL, 0.96 mmol) and methanesulfonyl chloride (0.03 mL, 0.41 mmol) were added to the solution and the mixture was stirred 5 min at 0°C and 5 min at room temperature. The organic layer was washed with water (15 mL), dried over MgSO 4 , filtrated and evaporated. The residue was purified by silica gel chromatography using dichloromethane/methanol, vol.2

M. Filip and M. Bader, Pharmacol. Reports, vol.61, pp.761-777, 2009.

L. F. Mohammad-zadeh, L. Moses, and S. M. Gwaltney-brant, J. Vet. Pharmacol. Ther, vol.31, pp.187-199, 2008.

A. E. Linder, W. Ni, J. L. Diaz, T. Szasz, R. Burnett et al., J. Pharmacol. Exp. Ther, vol.323, pp.415-421, 2007.

R. Ursin, Sleep Med. Rev, vol.6, pp.55-67, 2002.

J. E. Blundell, C. L. Lawton, and J. C. Halford, Obes. Res, vol.3, pp.471-476, 1995.

M. Buhot, S. Martin, and L. Segu, Ann. Med, vol.32, pp.210-221, 2000.

S. N. Young, M. Leyton, and . Pharmacol, Biochem. Behav, vol.71, pp.857-865, 2002.

D. Hoyer, D. E. Clarke, J. R. Fozard, P. R. Hartig, G. R. Martin et al., Pharmacol. Rev, vol.46, pp.157-203, 1994.

J. Masson, M. B. Emerit, M. Hamon, M. W. Darmon, and . Interdiscip, Rev. Membr. Transp. Signal, vol.1, pp.685-713, 2012.

S. C. Lummis, J. Biol. Chem, vol.287, pp.40239-40245, 2012.

J. Bockaert, J. P. Pin, C. Zuker, and . Embo-j, , vol.18, pp.1723-1729, 1999.

M. A. Wall, D. E. Coleman, E. Lee, J. A. Iaiguez-lluhi, B. A. Posner et al., Ft Sprang, S. Cell, vol.83, pp.1047-1058, 1995.

C. Denis, A. Saulière, S. Galandrin, J. Sénard, and C. Galés, Curr. Pharm. Des, vol.18, pp.128-144, 2012.

P. J. Conn and E. Sanders-bush, Neuropharmacology, vol.23, pp.993-996, 1984.

M. Maillet, S. Robert, and F. Lezoualc'h, Curr. Alzheimer Res, vol.1, pp.79-85, 2004.

A. Dumuis, R. Bouhelal, M. Sebben, and J. Bockaert, Eur. J. Pharmacol, vol.146, pp.187-188, 1988.

J. Bockaert, S. Claeysen, V. Compan, and A. Dumuis, Curr. Drug Targets. CNS Neurol. Disord, vol.3, pp.39-51, 2004.

D. T. Beattie and J. A. Smith, Naunyn-Schmiedeberg's Archives of Pharmacology, pp.181-203, 2008.

E. Qvigstad, T. Brattelid, I. Sjaastad, K. Andressen, K. W. Krobert et al., Cardiovasc. Res, vol.65, pp.869-878, 2005.

R. M. Eglen, E. H. Wong, A. Dumuis, and J. Bockaert, Trends Pharmacol. Sci, vol.16, pp.391-398, 1995.

N. Manabe, B. S. Wong, and M. Camilleri, Expert Opin. Investig. Drugs, vol.19, pp.765-775, 2010.

A. J. Kaumann, Trends Pharmacol. Sci, vol.15, pp.451-455, 1994.

M. Tonini and S. M. Candura, Trends Pharmacol. Sci, vol.17, pp.314-316, 1996.

A. Jean, G. Conductier, C. Manrique, C. Bouras, P. Berta et al., Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.16335-16340, 2007.

G. Lucas, V. Rymar, and . V;,

J. Du, O. Mnie-filali, C. Bisgaard, S. Manta, L. Lambas-senas et al., Neuron, vol.55, pp.712-725, 2007.

M. Matsumoto, H. Togashi, K. Mori, K. Ueno, S. Ohashi et al., J. Pharmacol. Exp. Ther, p.296, 2001.

A. Meneses, E. Hong, and . Pharmacol, Biochem. Behav, vol.56, pp.347-351, 1997.

G. P. Reynolds, S. L. Mason, A. Meldrum, S. De-keczer, H. Parnes et al., Br. J. Pharmacol, vol.114, pp.993-998, 1995.

E. H. Wong, G. P. Reynolds, D. W. Bonhaus, S. Hsu, R. M. Eglen et al., Brain Res, vol.73, pp.249-252, 1995.

D. W. Dickson, J. Neuropathol. Exp. Neurol, vol.56, pp.321-339, 1997.

S. Gandy, J. Clin. Invest, vol.115, pp.1121-1129, 2005.

M. Gralle, M. G. Botelho, and F. S. Wouters, J. Biol. Chem, vol.284, pp.15016-15025, 2009.

T. Harkany, I. Abrahám, C. Kónya, C. Nyakas, M. Zarándi et al., Rev. Neurosci, vol.11, pp.329-382, 2000.

M. Cochet, R. Donneger, E. Cassier, F. Gaven, S. F. Lichtenthaler et al., ACS Chem. Neurosci, vol.4, pp.130-140, 2013.

M. Maillet, S. J. Robert, M. Cacquevel, M. Gastineau, D. Vivien et al., Nat. Cell Biol, vol.5, p.633, 2003.

N. Zaldua, M. Gastineau, M. Hoshino, F. Lezoualc'h, J. L. Zugaza et al., , vol.581, pp.5814-5818, 2007.

S. J. Robert, J. L. Zugaza, R. Fischmeister, A. M. Gardier, and F. Lezoualc'h, J. Biol. Chem, vol.276, pp.44881-44888, 2001.

S. Cho and Y. Hu, 39) Lezoualc'h, F, vol.203, pp.325-329, 2007.

R. Bureau, M. Boulouard, F. Dauphin, F. Lezoualc'h, and S. Rault, Curr. Top. Med. Chem, vol.10, pp.527-553, 2010.

L. M. Gaster and F. D. King, Med. Res. Rev, vol.17, issue.2, pp.163-214, 1997.

M. L. López-rodríguez, M. J. Morcillo, B. Benhamú, and M. L. Rosado, J. Comput. Aided. Mol. Des, vol.11, pp.589-599, 1997.

R. Bureau, C. Daveu, S. Lemaître, F. Dauphin, H. Landelle et al., J. Chem. Inf. Comput. Sci, vol.42, issue.4, pp.962-967, 2002.

J. D. Gale, C. J. Grossman, J. W. Whitehead, A. W. Oxford, K. T. Bunce et al., Br. J. Pharmacol, vol.111, pp.332-338, 1994.

L. M. Gaster, A. J. Jennings, G. F. Joiner, F. D. King, K. R. Mulholland et al., J. Med. Chem, vol.36, pp.4121-4123, 1993.

L. M. Gaster, G. F. Joiner, F. D. King, P. A. Wyman, J. M. Sutton et al., J. Med. Chem, vol.38, pp.4760-4763, 1995.

J. K. Kjekshus, C. Torp-pedersen, L. Gullestad, L. Køber, T. Edvardsen et al., Eur. J. Heart Fail, vol.11, pp.771-778, 2009.

K. Buchheit, R. Gamse, R. Giger, D. Hoyer, F. Klein et al., J. Med. Chem, vol.38, pp.2326-2330, 1995.

M. N. Iskander, I. M. Coupar, and D. A. Winkler, J. Chem. Soc. Perkin Trans, vol.2, pp.153-158, 1999.

R. Bureau, T. Varin, A. Lepailleur, C. Daveu, S. Lemaitre et al., Curr. Comput. Aided-Drug Des, vol.4, pp.199-208, 2008.

J. Tack, M. Camilleri, L. Chang, W. D. Chey, J. J. Galligan et al., Aliment. Pharmacol. Ther, vol.35, pp.745-767, 2012.

M. A. Brodney, D. E. Johnson, A. Sawant-basak, K. J. Coffman, E. M. Drummond et al., J. Med. Chem, vol.55, pp.9240-9254, 2012.

S. Webb and H. O. Anger, Acta Oncol. (Madr), vol.48, issue.54, pp.515-531, 1964.

D. Delacroix, J. Guerre, and P. Leblanc, Guide pratique radionucléides et radioprotection : manuel pour la manipulation de substances radioactives dans les laboratoires de faible et moyenne activité, 2006.

, Thériaque, 2018.

S. E. Sharp, A. T. Trout, B. D. Weiss, M. J. Gelfand, and . Radiographics, , vol.36, pp.258-278, 2016.

D. S. Djang, M. J. Janssen, N. Bohnen, J. Booij, T. A. Henderson et al., J. Nucl. Med, vol.53, pp.154-163, 2012.

A. B. Newberg, N. A. Wintering, K. Plössl, J. Hochold, M. G. Stabin et al., J. Nucl. Med, vol.47, pp.748-754, 2006.

M. Ono and H. Saji, Int. J. Mol. Imaging, 2011.

H. F. Kung, H. Kim, M. Kung, S. K. Meegalla, K. Plössl et al., Eur. J. Nucl. Med, vol.23, pp.1527-1530, 1996.

J. Moretti, G. Defer, L. Cinotti, P. Cesaro, J. Degos et al., Eur. J. Nucl. Med, vol.16, pp.17-22, 1990.

M. Demedts, M. De-roo, P. Devos, L. Billiet, and J. Cosemans, Eur. J. Nucl. Med, vol.2, pp.9-12, 1977.

L. M. Paterson, B. R. Kornum, D. J. Nutt, V. W. Pike, and G. M. Knudsen, Med. Res. Rev, vol.33, pp.54-111, 2013.

R. N. Waterhouse, Mol. Imaging Biol, vol.5, pp.376-389, 2003.

V. W. Pike, C. Halldin, K. Nobuhara, J. Hiltunen, R. S. Mulligan et al., Eur. J. Nucl. Med. Mol. Imaging, vol.30, pp.1520-1528, 2003.

A. J. Kaumann, L. M. Gaster, F. D. King, and A. M. Brown, Naunyn. Schmiedebergs. Arch. Pharmacol, vol.349, pp.546-548, 1994.

C. Waeber, M. Sebben, J. Bockaert, A. Dumuis, and . Behav, Brain Res, vol.73, pp.259-262, 1995.

R. Chang and . Chemistry,

P. Mcgraw-hill-;-som, H. L. Atkins, D. Bandoypadhyay, J. S. Fowler, R. R. Macgregor et al., J. Nucl. Med, vol.21, issue.70, pp.670-675, 1980.

W. Zhang, S. Oya, M. Kung, C. Hou, D. L. Maier et al., Nucl. Med. Biol, vol.32, pp.799-809, 2005.

D. F. Wong, A. R. Moghekar, D. Rigamonti, J. R. Bra?i?, O. Rousset et al., Mol. Imaging Biol, vol.15, pp.230-237, 2013.

A. W. Glaudemans, R. H. Enting, M. A. Heesters, R. A. Dierckx, R. W. Van-rheenen et al., Eur. J. Nucl. Med. Mol. Imaging, vol.40, pp.615-635, 2013.

P. Castellucci, C. Fuccio, D. Rubello, R. Schiavina, I. Santi et al., Eur. J. Nucl. Med. Mol. Imaging, vol.38, pp.55-63, 2011.

S. Houle, N. Ginovart, D. Hussey, J. H. Meyer, and A. A. Wilson, Eur. J. Nucl. Med, vol.27, pp.1719-1722, 2000.

B. R. Kornum, N. M. Lind, N. Gillings, L. Marner, F. Andersen et al., Blood Flow Metab, vol.29, pp.186-196, 2009.

A. Gee, L. Martarello, J. Passchier, M. Wishart, C. Parker et al., , vol.1, pp.110-114, 2008.

L. Marner, N. Gillings, R. A. Comley, W. F. Baaré, E. A. Rabiner et al., J. Nucl. Med, vol.50, pp.900-908, 2009.

R. Xu, J. Hong, C. L. Morse, and V. W. Pike, J. Med. Chem, vol.53, pp.7035-7047, 2010.

T. G. Lohith, R. Xu, T. Tsujikawa, C. L. Morse, K. B. Anderson et al., , vol.68, pp.613-623, 2014.

F. Caillé, T. J. Morley, A. A. Tavares, C. Papin, N. M. Twardy et al., Bioorganic Med. Chem. Lett, vol.23, pp.6243-6247, 2013.

H. J. Buiter, A. D. Windhorst, M. C. Huisman, J. H. De-maeyer, J. A. Schuurkes et al., , p.24, 2013.

A. Hinschberger, S. Butt, V. Lelong, M. Boulouard, A. Dumuis et al., J. Med. Chem, vol.46, pp.138-147, 2003.

S. Lemaître, A. Lepailleur, R. Bureau, S. Butt-gueulle, V. Lelong-boulouard et al., Bioorg. Med. Chem, vol.17, pp.2607-2622, 2009.

S. Rault, J. Lancelot, H. Prunier, M. Robba, P. Renard et al., Eur. J. Med. Chem, vol.39, issue.86, pp.5465-5467, 1996.

E. Dubost, N. Dumas, C. Fossey, R. Magnelli, S. Butt-gueulle et al., J. Med. Chem, vol.55, pp.9693-9707, 2012.

N. Fresneau, N. Dumas, B. B. Tournier, C. Fossey, C. Ballandonne et al., Eur. J. Med. Chem, vol.94, pp.386-396, 2015.

C. Heiss, E. Marzi, F. Mongin, and M. Schlosser, European J. Org. Chem, issue.4, pp.669-675, 2007.

T. Cailly, F. Fabis, and S. Rault, Tetrahedron, vol.62, pp.5862-5867, 2006.

N. Fresneau, T. Cailly, F. Fabis, and J. Bouillon, Tetrahedron, vol.69, pp.5393-5400, 2013.

A. Leo, C. Hansch, and D. Elkins, Chem. Rev, vol.71, pp.525-616, 1971.

K. J. Valkó and . Chromatogr, , vol.1037, pp.299-310, 2004.

E. J. Stéen, N. Nyberg, S. Lehel, V. L. Andersen, P. Di-pilato et al., Bioorg. Med. Chem. Lett, vol.27, pp.319-322, 2017.

M. J. Waring, Expert Opin. Drug Discov, vol.5, pp.235-248, 2010.

M. J. Waring, Bioorg. Med. Chem. Lett, vol.19, pp.2844-2851, 2009.

C. Kramer, T. Heinisch, T. Fligge, B. Beck, and . Clark, , vol.4, pp.1529-1536, 2009.

A. F. Nassar, A. M. Kamel, and C. Clarimont, Drug Discov. Today, vol.9, pp.1020-1028, 2004.

D. F. Lewis, Dickins, M. Drug Discov. Today, vol.7, pp.918-925, 2002.

M. J. Waring and C. Johnstone, Bioorg. Med. Chem. Lett, vol.17, pp.1759-1764, 2007.

T. W. Johnson, R. A. Gallego, M. P. Edwards, J. A. Smith, D. T. Beattie et al., Naunyn. Schmiedebergs. Arch. Pharmacol, vol.61, issue.102, pp.125-137, 2008.

R. M. Mckinnell, S. R. Armstrong, D. T. Beattie, P. R. Fatheree, D. D. Long et al., Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties, vol.23, 2013.

T. Tsubouchi, T. Kunimatsu, S. Tsujimoto, A. Kiyoshi, Y. Katsura et al., Eur. J. Pharmacol, vol.826, pp.96-105, 2018.

V. Gomez-parra, F. Sanchez, and T. Torres, Synthesis (Stuttg), pp.282-285, 1985.

M. Yoshida, N. Hara, and S. Okuyama, Chem. Commun, vol.0, pp.151-152, 2000.

A. B. Reitz, G. R. Smith, and M. H. Parker, Expert Opin. Ther. Pat, vol.19, pp.1449-1453, 2009.

Y. Maeda, K. Saito, N. Akamatsu, Y. Chiba, S. Ohno et al., J. Am. Chem. Soc, vol.134, pp.18101-18108, 2012.

M. Hossain, U. Das, N. Umemura, H. Sakagami, J. Balzarini et al., J. R. Bioorg. Med. Chem, vol.24, pp.2206-2214, 2016.

J. Lohier, T. Glachet, H. Marzag, A. Gaumont, and V. Reboul, Chem. Commun, vol.53, pp.2064-2067, 2017.

M. Gensini, M. Altamura, T. Dimoulas, V. Fedi, D. Giannotti et al., , vol.5, pp.65-78, 2010.

D. W. Widlicka, J. C. Murray, K. J. Coffman, C. Xiao, M. A. Brodney et al., Org. Process Res. Dev, vol.20, pp.233-241, 2016.

J. C. Sutton, S. A. Bolton, M. E. Davis, K. S. Hartl, B. Jacobson et al., Bioorg. Med. Chem. Lett, vol.14, pp.2233-2239, 2004.

R. Appel, . Angew, and . Int, , vol.14, pp.801-811, 1975.

C. Yung-chi and W. H. Prusoff, Biochem. Pharmacol, vol.22, pp.3099-3108, 1973.

P. D. Leeson and B. Springthorpe, Nat. Rev. Drug Discov, vol.6, pp.881-890, 2007.

S. Mushtaq, J. Jeon, A. Shaheen, B. S. Jang, and S. H. Park, J. Radioanal. Nucl. Chem, vol.309, pp.859-889, 2016.

S. R. Donohue, K. Varnäs, Z. Jia, B. Gulyás, V. W. Pike et al., Bioorg. Med. Chem. Lett, vol.19, pp.6209-6212, 2009.

D. Wang, C. Wang, and M. Uchiyama, J. Am. Chem. Soc, vol.137, pp.10488-10491, 2015.

R. J. Linderman, In Encyclopedia of Reagents for Organic Synthesis

T. Morita, S. Fuse, H. Nakamura, and . Angew, Chemie Int, vol.55, pp.13580-13584, 2016.

J. E. Pickett, A. Váradi, T. C. Palmer, S. G. Grinnell, J. M. Schrock et al., Pd-catalyzed stannylation of radioiodination targets, vol.25, 2015.

B. Valeur, Invitation à la fluorescence moléculaire

D. Boeck, , 2004.

M. M. Martin, L. J. Lindqvist, and . Lumin, , vol.10, pp.381-390, 1975.

S. Mordon, J. M. Devoisselle, and V. Maunoury, Photochem. Photobiol, vol.60, pp.274-279, 1994.

Z. Ma, L. Du, M. Li, I. Berque-bestel, J. Soulier et al., J. Med. Chem, vol.57, issue.127, pp.2606-2620, 2003.

D. Yang, J. Soulier, S. Sicsic, M. Mathé-allainmat, B. Brémont et al., J. Med. Chem, vol.40, pp.608-621, 1997.

L. Cavina, D. Van-der-born, P. H. Klaren, M. C. Feiters, O. C. Boerman et al., European J. Org. Chem, issue.129, pp.3387-3414, 2017.

S. Venturi and M. Venturi, Nutr. Health, vol.20, pp.119-134, 2009.

S. M. Qaim, G. Stöcklin, . Radiochim, F. Acta-;-tárkányi, S. M. Qaim et al., Int. J. Radiat. Appl. Instrumentation. Part A. Appl. Radiat. Isot, vol.34, issue.132, pp.221-228, 1983.

R. M. Lambrecht, M. Sajjad, M. A. Qureshi, and S. J. Al-yanbawi, J. Radioanal. Nucl. Chem. Lett, vol.127, pp.143-150, 1988.

N. Karpuz, ?. Akkurt, and B. Mavi, Ann. Nucl. Energy, vol.60, pp.341-343, 2013.

W. G. Myers, J. Nucl. Med, vol.25, pp.1389-1391, 1984.

H. H. Coenen, J. Mertens, and B. Mazière, Radioionidation reactions for radiopharmaceuticals : compendium for effective synthesis strategies, 2006.

J. Chezal, J. Papon, P. Labarre, C. Lartigue, M. Galmier et al., N. J. Med. Chem, vol.51, pp.3133-3144, 2008.

T. De-paulis, A. Janowsky, R. M. Kessler, J. A. Clanton, and H. E. Smith, J. Med. Chem, vol.31, pp.2027-2033, 1988.

P. Kothari, B. P. De, B. He, A. Chen, M. J. Chiuchiolo et al., , vol.7, p.39594, 2017.

Y. Xu, M. Yang, D. Pan, L. Wang, K. Bapat et al., J. Radioanal. Nucl. Chem, vol.288, issue.141, pp.389-393, 2005.

P. M. Herrinton, P. M. Owen, C. E. Gage, J. R. Joyal, J. L. Barrett et al., Org. Process Res. Dev, vol.5, issue.143, pp.4045-4053, 2001.

D. T. Racys, S. A. Sharif, S. L. Pimlott, and A. Sutherland, J. Org. Chem, vol.81, issue.144, pp.772-780, 2016.

T. Yamamoto, K. Toyota, and N. Morita, Tetrahedron Lett, vol.51, pp.1364-1366, 2010.

S. M. Moerlein, J. Chem. Soc. Perkin Trans. 1, vol.0, pp.1687-1692, 1985.

G. Vaidyanathan, M. R. Zalutsky, J. Lalut, B. B. Tournier, T. Cailly et al., Appl. Radiat. Isot, vol.44, issue.148, pp.90-101, 1993.

A. A. Cant, S. Champion, R. Bhalla, S. L. Pimlott, and A. Sutherland, Angew. Chemie Int. Ed, vol.52, pp.7829-7832, 2013.

M. Tredwell, S. M. Preshlock, N. J. Taylor, S. Gruber, M. Huiban et al., , vol.53, pp.7751-7755, 2014.

T. C. Wilson, G. Mcsweeney, S. Preshlock, S. Verhoog, M. Tredwell et al., Chem. Commun, vol.52, pp.13277-13280, 2016.

S. ;. Webster, K. M. O'rourke, C. Fletcher, S. L. Pimlott, A. Sutherland et al., Eur. J, vol.24, pp.937-943, 2018.

S. W. Reilly, M. Makvandi, K. Xu, and R. H. Mach, Org. Lett, vol.20, pp.1752-1755, 2018.

N. L. Sloan, S. K. Luthra, G. Mcrobbie, S. L. Pimlott, and A. Sutherland, Chem. Commun, vol.53, pp.11008-11011, 2017.

K. Yuan and H. Doucet, Chem. Sci, vol.5, pp.392-396, 2014.

J. Dupont, C. S. Consorti, J. Spencer, T. Gensch, M. N. Hopkinson et al., J. Chem. Soc. Rev, vol.105, issue.157, pp.2900-2936, 2005.

K. M. Engle and J. Yu, J. Org. Chem, vol.78, pp.8927-8955, 2013.

Z. Chen, B. Wang, J. Zhang, W. Yu, Z. Liu et al., Org. Chem. Front, vol.2, pp.1107-1295, 2015.

J. Hu, G. Li, Z. Huang, J. Zhang, D. Shi et al., Org. Chem. Front, vol.4, pp.1503-1507, 2017.

Z. She, Y. Shi, Y. Huang, Y. Cheng, F. Song et al., J. Chem. Commun, vol.50, pp.13914-13916, 2014.

X. Wang, X. Ji, C. Shao, Y. Zhang, and Y. Zhang, Org. Biomol. Chem, vol.15, pp.5616-5624, 2017.

Y. Park, Y. Kim, and S. Chang, Chem. Rev, vol.117, pp.9247-9301, 2017.

W. Lu, H. Xu, and . Shen, Z. Org. Biomol. Chem, vol.15, pp.1261-1267, 2017.

M. Murai, N. Nishinaka, and K. Takai, Angew. Chemie Int. Ed, vol.57, pp.5843-5847, 2018.

R. Das, M. J. Kapur, and . Org, , vol.82, pp.1114-1126, 2017.

L. Ackermann, Chem. Rev, vol.111, pp.1315-1345, 2011.

T. W. Lyons and M. S. Sanford, Chem. Rev, vol.110, pp.1147-1169, 2010.

D. C. Powers, M. A. Geibel, J. E. Klein, T. Ritter, J. A. Brown et al., Adv. Synth. Catal, vol.131, issue.170, pp.3551-3562, 2009.

H. Yang, P. G. Dormer, N. R. Rivera, A. J. Hoover, and . Angew, Chemie Int. Ed, vol.57, pp.1883-1887, 2018.

F. Péron, C. Fossey, . Sopkova-de-oliveira, J. Santos, T. Cailly et al., J, vol.20, pp.7507-7513, 2014.

R. Giri, X. Chen, and J. Yu, Angew. Chemie Int. Ed, vol.44, pp.2112-2115, 2005.

T. Mei, R. Giri, N. Maugel, J. Yu, and . Angew, Chemie Int, vol.47, pp.5215-5219, 2008.

T. Mei, D. Wang, and J. Yu, Org. Lett, vol.12, pp.3140-3143, 2010.

J. Li, T. Mei, and J. Yu, Angew. Chemie Int. Ed, vol.47, pp.6452-6455, 2008.

R. Giri, X. Chen, X. Hao, J. Li, J. Liang et al., Tetrahedron: Asymmetry, vol.16, pp.3502-3505, 2005.

P. Zhang, L. Hong, G. Li, and R. Wang, Adv. Synth. Catal, vol.357, pp.345-349, 2015.

X. Wang, Y. Hu, S. Bonacorsi, Y. Hong, R. Burrell et al., J. Am. Chem. Soc, vol.135, pp.10326-10329, 2013.

Y. Aihara, N. Chatani, and . Acs-catal, , vol.6, pp.4323-4329, 2016.

Y. Kommagalla, K. Yamazaki, T. Yamaguchi, and N. Chatani, Chem. Commun, vol.54, pp.1359-1362, 2018.

A. R. Dick,

K. L. Hull, A. Sanford, and M. S. , J. Am. Chem. Soc, vol.126, pp.2300-2301, 2004.

D. Kalyani, A. R. Dick, W. Q. Anani, and M. S. Sanford, Org. Lett, vol.8, pp.2523-2526, 2006.

D. Kalyani, A. R. Dick, W. Q. Anani, and M. S. Sanford, Tetrahedron, vol.62, pp.11483-11498, 2006.

F. M. Moghaddam, G. Tavakoli, B. Saeednia, P. Langer, and B. Jafari, J. Org. Chem, vol.81, pp.3868-3876, 2016.

B. Du, X. Jiang, and P. Sun, J. Org. Chem, vol.78, pp.2786-2791, 2013.

X. Ma and S. Tian, Adv. Synth. Catal, vol.355, pp.337-340, 2013.

P. R. Hartig, A. M. Krohn, and S. A. Hirschman, Anal. Biochem, vol.144, pp.441-446, 1985.

A. Ammazzalorso, B. De-filippis, L. Giampietro, and R. Amoroso, Chem. Biol. Drug Des, vol.90, pp.1094-1105, 2017.

K. L. Lobb, P. A. Hipskind, J. A. Aikins, E. Alvarez, Y. Cheung et al., J. Med. Chem, vol.47, pp.5367-5380, 2004.

T. Meier, M. Uhlik, S. Chintharlapalli, M. Dowless, R. Van-horn et al., Mol. Cancer Ther, vol.10, pp.2168-2178, 2011.

M. F. Rega, B. Wu, J. Wei, Z. Zhang, J. F. Cellitti et al., J. Med. Chem, vol.54, pp.6000-6013, 2011.

R. Giri, J. K. Lam, and J. Yu, J. Am. Chem. Soc, vol.132, pp.686-693, 2010.

R. B. Bedford, M. F. Haddow, C. J. Mitchell, and R. L. Webster, Angew. Chemie Int. Ed, vol.50, pp.5524-5527, 2011.

K. M. Engle, T. Mei, M. Wasa, and J. Yu, Acc. Chem. Res, vol.45, pp.788-802, 2012.

E. A. Kantchev and J. Y. Ying, Organometallics, vol.28, pp.289-299, 2009.

A. P. Smalley and M. J. Gaunt, J. Am. Chem. Soc, vol.137, pp.10632-10641, 2015.

A. Mcnally, B. Haffemayer, B. S. Collins, M. J. Gaunt, E. Laga et al., Eur. J, vol.510, pp.17398-17412, 2013.

S. Nieto, P. Arnau, E. Serrano, R. Navarro, T. Soler et al., Inorg. Chem, vol.48, pp.11963-11975, 2009.

P. Gandeepan, K. Parthasarathy, and C. Cheng, J. Am. Chem. Soc, vol.132, pp.8569-8571, 2010.

X. Sun, G. Shan, Y. Sun, and Y. Rao, Angew. Chemie Int. Ed, vol.52, pp.4440-4444, 2013.

J. Wang, C. Dong, L. Wu, M. Xu, J. Lin et al., Adv. Synth. Catal, vol.19, issue.204, pp.468-469, 2010.

S. R. Hingorani, M. A. Jacobetz, G. P. Robertson, M. Herlyn, D. A. Tuveson et al., P. A. Cancer Res, vol.63, pp.5198-5202, 2003.

H. Yoshida, H. Yanai, Y. Namiki, K. Fukatsu-sasaki, N. Furutani et al., CNS Drug Rev, vol.12, pp.9-20, 2006.

A. Barqawi, B. Akduman, Z. Abouelfadel, M. Robischon, E. D. Crawford et al., , vol.92, pp.695-698, 2003.

L. Pisani, R. Farina, M. Catto, R. M. Iacobazzi, O. Nicolotti et al., J. Med. Chem, vol.59, pp.6791-6806, 2016.

X. Kong, Z. He, Y. Zhang, L. Mu, C. Liang et al.,

. Lett, , vol.13, pp.764-767, 2011.

M. E. Ashford, V. H. Nguyen, I. Greguric, T. Q. Pham, P. A. Keller et al., Org. Biomol. Chem, vol.12, pp.783-794, 2014.

E. Dubost, R. Magnelli, T. Cailly, R. Legay, F. Fabis et al., Tetrahedron, vol.66, pp.5008-5016, 2010.

Z. Sang, K. Wang, H. Wang, L. Yu, H. Wang et al., Bioorg. Med. Chem. Lett, vol.27, pp.5053-5059, 2017.

Y. Chen, S. Wang, X. Xu, X. Liu, M. Yu et al., J. Med. Chem, vol.56, pp.4671-4690, 2013.

F. Péron, C. Fossey, T. Cailly, and F. Fabis, Org. Lett, vol.14, pp.1827-1829, 2012.

S. Kathiravan, I. A. Nicholls, . Chem, H. Song, Y. Liu et al., Org. Lett, vol.23, pp.3240-3243, 2014.

U. Ladziata, A. Y. Koposov, K. Y. Lo, J. Willging, V. N. Nemykin et al., , vol.44, pp.7127-7131, 2005.

A. Ahmed, R. Singha, and J. K. Ray, Tetrahedron Lett, vol.56, pp.2167-2171, 2015.

M. Chaitanya and P. Anbarasan, Org. Lett, vol.20, pp.3362-3366, 2018.

B. Song, X. Zheng, J. Mo, and B. Xu, Adv. Synth. Catal, vol.352, pp.329-335, 2010.

A. Hafner, M. Meisenbach, and J. Sedelmeier, Org. Lett, vol.18, pp.3630-3633, 2016.